Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 800 results for "sandoz inc"

Amgen And Sandoz Do Biosimilar Patent Dance Over Neulasta

Amgen Inc. has filed a complaint under the Biologics Price Competition and Innovation Act (BPCIA) , asserting that a biosimilar application filed by Sandoz Inc. seeking approval of a biosimilar version of Neulasta® infringes two of its patents. National Law Review, 1 month ago
Share Market Updates

HC Stocks Growth: Pfizer Inc. (NYSE:PFE), Apricus Biosciences Inc (NASDAQ:APRI)

Shares of Pfizer Inc. (NYSE:PFE ) ended Thursday session in green amid volatile trading. The shares closed up +0.12 points or 0.35 % at $ 34.59 with 23.82 million shares getting traded. Post opening the session at $ 34.70 , the shares hit an ...
 Share Market Updates4 days ago HC Stocks in Top Row: Threshold Pharmaceuticals, Inc. (NASDAQ:THLD), Intercept Pharmaceuticals Inc (NASDAQ:ICPT)  Share Market Updates2 weeks ago Anacor reveals receiving rival bid before Pfizer deal - filing  Yahoo! Finance1 month ago Anacor received rival bid before Pfizer deal - filing  Reuters UK1 month ago
[x]  

AbbVie Inc Pipeline May Not Compensate for Humira's Loss

AbbVie Inc ( NYSE:ABBV ) is having one of its worst weeks. The company showcased its pipeline at an R&D event on June 1 and disclosed clinical data at this year's American Society of Clinical Oncology (ASCO) meeting over the past weekend. Analysts ...
 Bidness Etc2 weeks ago Should AbbVie Inc (ABBV) Feel Threatened By Coherus Humira Patent Challenge?  Bidness Etc1 month ago
Bidness Etc

Why Amgen, Inc. (AMGN) is a Strong Buy Right Now

Amgen is a good buy for investors, as the company has blockbuster drugs and a fine R&D facility The recent sell off in the biotech sector has raised high return potential of investment opportunities in large stocks. So far this year, the sector ...
 Bidness Etc2 weeks ago Fitch Rates Amgen Inc. Notes Offering 'BBB'; Outlook Stable  4 Traders1 month ago
[x]  

BRIEF-Spectrum Pharmaceuticals unit, Allos Therapeutics and Sandoz enter settlement agreement

June 9 Spectrum Pharmaceuticals Inc : * On June 8, 2016, co's unit , Allos Therapeutics and Sandoz Inc entered into a settlement agreement * Spectrum Pharmaceuticals Inc says settlement agreement to resolve patent litigation relating to ...
 Reuters UK2 weeks ago Spectrum Pharmaceuticals' unit, Allos Therapeutics and Sandoz enter settlement agreement  Reuters UK2 weeks ago

Sandoz broadens its pharmaceutical portfolio with acquisition of EURO-PHARM product line

/CNW/ - Sandoz Canada will increase the number and range of products it offers to Canadians following the acquisition by its parent company Sandoz AG - of the North American product portfolio of Montreal-based Euro-Pharm International Canada Inc.
 Canada NewsWire4 weeks ago
Powder Bulk Solids

Pfizer to Acquire Anacor

Pfizer Inc. and Anacor Pharmaceuticals, Inc. announced that they have entered into a definitive merger agreement under which Pfizer will acquire Anacor for $99.25 per Anacor share, in cash, for a total transaction value, net of cash, of ...
 Executive Insight3 weeks ago Pfizer Enters Merger Agreement with Anacor  Powder Bulk Solids1 month ago
Nasdaq

Pfizer to Buy Anacor, Add Eczema Treatment to Portfolio

Pfizer Inc. PFE announced that it will be acquiring biopharmaceutical company, Anacor Pharmaceuticals, Inc. ANAC , for $99.25 per share or a total of about $5.2 billion (assuming the conversion of Anacor's outstanding convertible notes). Anacor's ...
 Zacks.com1 month ago Pfizer to buy California-based biopharma company, Anacor for $5.2 billion  PharmaBiz1 month ago
[x]  

Merck May Need More Than Just Bolt-On Acquisitions

Shares of Merck & Co. Inc. (NYSE: MRK ) have pulled back about 5.75% from the April high, along with the S&P 500 Healthcare sector, down 2.38%, on concerns about interest rate decisions from the Fed, and the Senate Special Committee on Aging's third ...
 Seeking Alpha1 month ago
Bidness Etc

Teva, Mylan, Endo: Why Generic Drug Prices Are Dropping

The stocks of companies that manufacture generic drugs are in trouble as the market faces pricing pressures brought on by increased consolidation, and an uptick in the number of regulatory approvals. According to data from Symphony Health, median ...
 Bidness Etc1 month ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less